Download PDF
1 / Pages

Other users also viewed these articles

Retreatment experience with Glecaprevir/Pibrentasvir (G/P) for hepatitis C infection in patients failing first-line direct-acting antiviral agents. Orestes J. Cobos-Quevedo; Ximena E. Cuenca-Avila; Leonardo S. Juárez-Chávez; Mauricio Castillo-Barradas; Enrique Carrera-Estupiñan; José L. Pérez-Hernández; María F. Higuera-De la Tijera;
Ann Hepatol. 2024;29 Supl 2:
BUN/creatinine ratio associated with mortality in patients with cirrhosis and acute kidney injury. Diego F. Abendaño-Rivera; Cristian Y Sánchez-Sánchez; Karina Cazarin-Chávez; Paloma M. Diego-Salazar; Daniel Santana-Vargas; María F. Higuera-De La Tijera; José L. Pérez-Hernández;
Ann Hepatol. 2024;29 Supl 2:
Regulation of TGF-ß1, 2, and 3 and IL-10 at systemic level in chronic liver disease Marisela Hernandez-Santillan; Abigail Hernandez-Barragan; Moises Martínez-Castillo; Zaira Medina-Ávila; Harumi Reséndiz-García; Erik Robledo-Ramírez; Yadira Guizar-Alcántara; Amanda Álvarez-Rodea; Danna Mercado-Herrera; María F. Higuera-De La Tijera; José L. Pérez-Hernández; Daniel Santana-Vargas; Gabriela Gutiérrez-Reyes;
Ann Hepatol. 2024;29 Supl 2: